振动结肠刺激囊治疗慢性便秘:一个系统的审查
Prakash Bruhan Math1, Renju Ravi1, Tahir Hakami1
1Department of Clinical Pharmacology, Faculty of Medicine, Jazan University, Jazan, Saudi Arabia.
Journal of medicine and life
|October 30, 2023
概括
一个新的振动性结肠刺激囊显示了慢性异常性便秘的前景,增加了肠道排便,并具有轻微的副作用. 需要更多的研究来证实其有效性和广泛使用的安全性.
科学领域:
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性异常性便秘 (CIC) 影响全球数百万人,需要新的治疗方法.
- 美国食品和药物管理局 (FDA) 在2022年8月批准了一种口服的振动结肠刺激囊用于CIC治疗.
结论:
- 振动结肠刺激囊在治疗慢性异常性便秘方面表现出有希望的疗效和安全性.
- 轻度不良事件包括振动感,腹和腹部不适;没有报告严重的治疗相关不良事件.
- 建议进行更大的随机临床试验,以便在广泛采用之前产生更强有力的证据.
相关概念视频
Drugs for Treatment of Constipation-Predominant IBS
181
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
181
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
220
Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
220
Chronic Bowel Disorders: Introduction
459
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
459
Drugs Affecting GI Tract Motility: Other Laxatives
241
Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
241
Irritable Bowel Syndrome III: Medical and Nursing Management
216
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
216
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
167
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
167


